increased after the treatment in a lower concentration (0.4, 0.8 ug/mL). SRSF1 expression appeared as a peak form. Conclusions: This study tells the expression of SRSF1 BIU-87 cells and its variation after chemotherapeutic drug (pirarubicin) treatment. In conclusion, SRSF1 may act as a useful potential target for bladder carcinoma therapies. Objective: Photoselective vaporization of the prostate (PVP) using GreenLight and Holmium laser enucleation of the prostate (HoLEP) is an important surgical technique for management of benign prostate hyperplasia (BPH). We aimed to compare the effectiveness and safety of PVP using
